[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338925-105":59,"doc-detail-338925-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","immunogenic-cell-death-in-colorectal-cancer-a-review-of-mechanisms-and-clinical-utility","Immunogenic cell death in colorectal cancer - a review of mechanisms and clinical utility","","Colorectal cancer (CRC) remains a major cause of cancer morbidity and mortality, with limited outcomes for advanced disease despite clinical advances. The immune system is central to cancer development and therapy response, while the intestinal mucosa is generally immunosuppressive. In the tumour microenvironment, anti-neoplastic treatments that cause cytotoxic and cytostatic effects can also trigger immunogenic cell death (ICD), a regulated process that provokes an anti-tumour immune response. The review summarizes current knowledge of ICD in CRC, including the need for novel ICD inducers and ICD action biomarkers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/immunogenic-cell-death-in-colorectal-cancer-a-review-of-mechanisms-and-clinical-utility/338925/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/immunogenic-cell-death-in-colorectal-cancer-a-review-of-mechanisms-and-clinical-utility/338925.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is immunogenic cell death (ICD) important in advanced colorectal cancer?","Question",{"text":112,"@type":113},"ICD is a regulated form of cell death that can be induced by certain anti-neoplastic treatments and leads to an anti-tumour immune response. This is sought to improve limited survival outcomes in advanced CRC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What are damage-associated molecular patterns (DAMPs) in ICD?",{"text":117,"@type":113},"DAMPs are intracellular biomolecules released or exposed by dying cells that have immunostimulatory properties. They include signals such as calreticulin and heat shock proteins, HMGB1, and nucleic-acid-related factors like ATP, DNA, and RNA.",{"name":119,"@type":110,"acceptedAnswer":120},"How do DAMPs translate into an anti-tumour immune response?",{"text":121,"@type":113},"DAMPs bind pattern recognition receptors on antigen-presenting cells, activating innate and adaptive immune responses. This promotes APC maturation and cross-priming of cytotoxic T lymphocytes, leading to tumour-specific responses and memory T cell generation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338925,1790148034,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Cancer Immunology, Immunotherapy (2024) 73:53 [https://doi.org/10.1007/s00262-024-03641-5](https://doi.org/10.1007/s00262-024-03641-5)  \nImmunogenic cell death in colorectal cancer: a review of mechanismsand clinical utility  \nM. De Silva1,2 · B. C. Y. Tse1 · C. I. Diakos2,3 · S. Clarke2,3 · M. P. Molloy1,3  \nReceived: 5 December 2023 / Accepted: 23 January 2024 / Published online: 14 February 2024 © The Author(s) 2024  \nAbstract  \nColorectal cancer (CRC) is a major cause of cancer-related morbidity and mortality worldwide. Despite several clinical advances the survival of patients with advanced colorectal cancer remains limited, demanding newer approaches. The immune system plays a central role in cancer development, propagation, and treatment response. Within the bowel, the colorectal mucosa is a key barrier and site of immune regulation that is generally immunosuppressive. Nonetheless, within this tumour microenvironment, it is evident that anti-neoplastic treatments which cause direct cytotoxic and cytostatic effects may also induce immunogenic cell death (ICD), a form of regulated cell death that leads to an anti-tumour immune response. Therefore, novel ICD inducers and molecular biomarkers of ICD action are urgently needed to advance treatment options for advanced CRC. This article reviews our knowledge of ICD in CRC.  \nKeywords Immunogenic cell death · Colorectal cancer · Chemotherapy · Damage-associated molecular patterns · Biomarker  \nIntroduction  \nThe global burden of colorectal cancer (CRC) is significant with some of the highest incidence rates observed in Australasia where it is the second leading cause of cancerrelated death [1, 2] . Despite improvements in bowel cancer screening, around 20% of patients present with advanced disease with a historical 5-year overall survival (OS) of 13%  \n[2] . Contemporary real-world series have demonstrated an increase in 5-year OS over the past decade to around 25%, with multivariate analyses attributing this to novel treatments for BRAF-mutated and microsatellite unstable (MSIH) disease, as well as more patients undergoing surgical resection of liver metastases and receiving third-line treatments [3] . Cytotoxic chemotherapy remains the backbone  \n* M. P. Molloy [m.molloy@sydney.edu.au](m.molloy@sydney.edu.au)  \n1 Bowel Cancer and Biomarker Research Laboratory, Kolling Institute, Royal North Shore Hospital, St Leonards, NSW, Australia  \n2 Department of Medical Oncology, Royal North Shore Hospital, St. Leonards, NSW, Australia  \n3 Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia  \nstandard systemic treatment for the majority of advanced CRC patients who typically harbour wild-type RAS/RAF and microsatellite stable tumours. The clinical activity of conventional chemotherapy for CRC has been attributed to direct cytotoxic and/or cytostatic effects. However, thereis increasing understanding that many of these treatments induce immunogenic cell death (ICD), a type of regulated cell death resulting in innate and adaptive anti-tumour immune responses that can enhance therapies [4, 5] . Great interest exists in identifying novel ICD inducers which may unlock the clinical activity of immunotherapeutics which are mostly missing for treating CRC patients. Less emphasis has been placed on the potential utility of ICD molecular features as novel biomarkers across cancers. The focus of this review is to describe the role and known mechanisms of ICD and review existing data regarding ICD biomarkers in CRC.  \nImmunogenic cell death and anti‑cancer therapy  \nCell death is an irreversible, stimulus-specific process which may be classified by morphologic, enzymatic, functional, and immunologic characteristics [6, 7] . Regulated cell death (RCD) is an evolutionarily conserved form of cell death  \ndriven by specific gene pathways and plays a crucial role in normal embryologic development and post-embryonic homeostasis [6, 7] . The most well-k","cbCaiuAetZsOhBSl","https://ap.wps.com/l/cbCaiuAetZsOhBSl","pdf",793960,"English","# Introduction\n## Immunogenic cell death and anti-cancer therapy\n## Immunogenic signals (DAMPs) and immune activation","[{\"question\":\"Why is immunogenic cell death (ICD) important in advanced colorectal cancer?\",\"answer\":\"ICD is a regulated form of cell death that can be induced by certain anti-neoplastic treatments and leads to an anti-tumour immune response. This is sought to improve limited survival outcomes in advanced CRC.\"},{\"question\":\"What are damage-associated molecular patterns (DAMPs) in ICD?\",\"answer\":\"DAMPs are intracellular biomolecules released or exposed by dying cells that have immunostimulatory properties. They include signals such as calreticulin and heat shock proteins, HMGB1, and nucleic-acid-related factors like ATP, DNA, and RNA.\"},{\"question\":\"How do DAMPs translate into an anti-tumour immune response?\",\"answer\":\"DAMPs bind pattern recognition receptors on antigen-presenting cells, activating innate and adaptive immune responses. This promotes APC maturation and cross-priming of cytotoxic T lymphocytes, leading to tumour-specific responses and memory T cell generation.\"}]","Immunogenic cell death in colorectal cancer - a review of mechanisms and clinical utility | PDF",1790026566,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1c036cb2643d1b963e130c5703dd62f.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74f946b57fcac387d07181b6e78de2da.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7ff5fca46bca09d26e6028fe7463253.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1744fa5e12fcbf076569085fb0ca7ca.webp",980,1301]